The current study aimed to investigate the role of PER2 modulation in the acquisition of aggressiveness and drug resistance in human HCC cell models rendering resistant to EVE (EveR cells), as well as an additional model resistant to SOR spawned after long-term in vitro exposure, defined SOR resistant (SorR) cells. Here, PER2 is linked to hepatocellular carcinoma.